{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-303104","form_type":"8-K","ticker":"KMTS","cik":"0001877184","company_name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","filed_at":"2025-12-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.947181+00:00","generated_at":"2026-05-16T15:55:09.425486+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Kestra Medical preliminary Q2 FY26 revenue up 52% YoY to $22.2-22.6M; gross margin improves to 50.0%","bullets":["Revenue expected $22.2-$22.6M vs $14.7M prior year (+52% at midpoint).","Gross profit $11.0-$11.4M (prior $5.8M); gross margin 50.0% vs 39.6%.","Loss from operations $31.6-$32.0M (prior year $19.1M), reflecting investment in growth.","Cash and equivalents ~$175M.","CEO cites commercial momentum and positive unit economics."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-303104","json":"https://secwatch.observer/filing/0001193125-25-303104.json","markdown":"https://secwatch.observer/filing/0001193125-25-303104.md","text":"https://secwatch.observer/filing/0001193125-25-303104.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1877184/000119312525303104/0001193125-25-303104-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1877184/000119312525303104/d944376d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T15:55:09.425486+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}